FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
8014
Conditions: Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer
Start Date: November 1, 2004
Phase: Phase I
Status: Recruiting
NCT ID: NCT00098644
Study Type: Interventional
Intervention: Drug: alvocidib|Drug: romidepsin
Study Design: Primary Purpose: Treatment
Results: No Results Available
Sponsors: National Cancer Institute (NCI)
Ages: Adult|Senior
Enrollment: 48
Funded By: NIH
First Received: December 7, 2004
End Date:
Last Updated: July 7, 2009
Last Verified: July 1, 2009